Skip to content
Drug Repositioning
Drug Repositioning


Drug Repositioning

In the context of BRFAA’s preclinical expertise on existing/established drugs, services are provided for drug repositioning computational studies preferably to sponsors which will present well-documented projects with specific proposals. The process includes initial Proof-of-Concept studies at the preclinical level in order to investigate:

  1. Route of administration
  2. New target engagement of the existing drugs and
  3. in vivo efficacy

Main goal is to build up a data package for clinical evaluation.


Partner Institute

Biomedical Research Foundation of the Academy of Athens

Biomedical Research Foundation of the Academy of Athens

Constantin Tamvakopoulos – Investigator A’, Professor Level
Center of Clinical, Experimental Surgery & Translational Research
Director of Research Pharmacology Lab
Biomedical Research Foundation, Academy of Athens (BRFAA)
Soranou Ephessiou 4
Athens, 11527
Tel: +30 210 6597 475
+30 210 6597 484